Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Goodwill (2019 - 2025)

Historic Goodwill for Lineage Cell Therapeutics (LCTX) over the last 7 years, with Q3 2025 value amounting to $10.7 million.

  • Lineage Cell Therapeutics' Goodwill changed 0.0% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.7 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Lineage Cell Therapeutics' Goodwill stood at $10.7 million, which was down 0.0% from $10.7 million recorded in Q2 2025.
  • Lineage Cell Therapeutics' 5-year Goodwill high stood at $10.7 million for Q1 2021, and its period low was $10.7 million during Q1 2021.
  • In the last 5 years, Lineage Cell Therapeutics' Goodwill had a median value of $10.7 million in 2021 and averaged $10.7 million.
  • Examining YoY changes over the last 5 years, Lineage Cell Therapeutics' Goodwill showed a top increase of 0.0% in 2021 and a maximum decrease of 0.0% in 2021.
  • Quarter analysis of 5 years shows Lineage Cell Therapeutics' Goodwill stood at $10.7 million in 2021, then changed by 0.0% to $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025.
  • Its Goodwill was $10.7 million in Q3 2025, compared to $10.7 million in Q2 2025 and $10.7 million in Q1 2025.